[SLRX] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
02-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 6.39%
YoY- -30.47%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 336 243 299 599 113 0 0 -
PBT -8,805 -8,268 -7,900 -10,637 -11,363 -9,592 -7,893 7.56%
Tax 0 0 -112 0 0 0 -15 -
NP -8,805 -8,268 -7,900 -10,637 -11,363 -9,592 -7,893 7.56%
Tax Rate - - - - - - - -
Total Cost 9,140 8,511 8,199 11,237 11,476 9,592 7,893 10.28%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -2,624.15 -3,408.99 -2,642.14 -1,775.66 -10,083.98 0.00 0.00 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -321.24 -306.27 -297.08 -406.35 -440.98 -378.42 -317.20 0.84%
EPS Diluted -321.24 -306.27 -297.08 -406.35 -440.98 -378.42 -317.20 0.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.